BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $460,000 | -13.7% | 8,700 | 0.0% | 0.00% | – |
| Q2 2020 | $533,000 | +20.9% | 8,700 | +11.5% | 0.00% | – |
| Q1 2020 | $441,000 | +9.2% | 7,800 | +9.9% | 0.00% | – |
| Q4 2019 | $404,000 | +6.3% | 7,100 | 0.0% | 0.00% | – |
| Q3 2019 | $380,000 | +8.0% | 7,100 | +20.3% | 0.00% | – |
| Q2 2019 | $352,000 | -7.4% | 5,900 | -3.3% | 0.00% | – |
| Q1 2019 | $380,000 | +2.7% | 6,100 | 0.0% | 0.00% | – |
| Q4 2018 | $370,000 | +31.7% | 6,100 | +27.1% | 0.00% | – |
| Q3 2018 | $281,000 | -64.6% | 4,800 | -71.9% | 0.00% | -100.0% |
| Q3 2017 | $794,000 | -31.6% | 17,070 | -27.1% | 0.00% | 0.0% |
| Q2 2017 | $1,160,000 | -48.1% | 23,420 | -42.6% | 0.00% | -50.0% |
| Q1 2017 | $2,237,000 | +393.8% | 40,820 | +401.8% | 0.00% | – |
| Q4 2016 | $453,000 | +1361.3% | 8,135 | +916.9% | 0.00% | – |
| Q1 2015 | $31,000 | +106.7% | 800 | +100.0% | 0.00% | – |
| Q4 2014 | $15,000 | +7.1% | 400 | 0.0% | 0.00% | – |
| Q3 2014 | $14,000 | -36.4% | 400 | -50.0% | 0.00% | – |
| Q2 2014 | $22,000 | +633.3% | 800 | +633.9% | 0.00% | – |
| Q1 2014 | $3,000 | +50.0% | 109 | 0.0% | 0.00% | – |
| Q4 2013 | $2,000 | 0.0% | 109 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | +100.0% | 109 | +36.2% | 0.00% | – |
| Q2 2013 | $1,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | 2,300 | $203,550,000 | 0.00% |